Search - tctmd.com

Displaying 381 - 400 of 455

Sort: Relevancy | Date

News Industry News

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

May 09, 2013

Presentation Fellows 2013

LAA Closure for Nonvalvular Atrial Fibrillation

Presenter: Mark Reisman

April 17, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

News Daily News

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Yael L. Maxwell

April 12, 2013

Presentation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Presenter: Vivek Y. Reddy

April 09, 2013

News Conference News ACC 2013

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

L.A. McKeown

March 14, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

Presentation TCT 2013

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

Presenter: Fazilatum Nesa Malik, Antonio Serra, Nick West, Werner Scholtz, Farzin FATH-ORDOUBADHI, Teguh Santoso, Peep Laanmets, Werner Jung, Fraser WITHEROW, Stefan HOFFMANN, Mohsen Mohandes, Gian Battista Danzi

January 31, 2013

Presentation TCT 2013

The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarctio...

Presenter: H. Boden, T.A.N. Ahmed, M.A. Velders, B.L. van der Hoeven, G.E. Hoogslag, M. Bootsma, S. le Cessie, C.M. Cobbaert, A. van der Laarse, M.J. Schalij

January 31, 2013

Presentation TCT 2013

Short and Long Term Clinical Outcomes of Left Main Treatment with a Latest Generation Drug Eluting Stent

Presenter: Bernard Chevalier, Christian Dina, Stefan HOFFMANN, Nikola Jagic, Yu Jiangtao, Ren? Koning, Ran Kornowski, Peep Laanmets, Zoran Perisic, Teguh Santoso

January 31, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

News Industry News

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

January 17, 2013

News Daily News

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

L.A. McKeown

January 16, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

Presentation

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Presenter: A. Massumi

January 14, 2013

Advertisement

New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The P

LAA Closure for Nonvalvular Atrial Fibrillation

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

The Clinical Utility of High-Sensitive Troponin T to Predict Infarct Size, Left Ventricular Function and Adverse Outcome in Patients with First ST Elevation Myocardial Infarctio...

Short and Long Term Clinical Outcomes of Left Main Treatment with a Latest Generation Drug Eluting Stent

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content